We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
According to a new market survey, cardiovascular drugs are the fastest-growing
therapeutic segment in India, with sales rising 14% to INR21.76bn (US$498.11mn)
in 2004.
SemBioSys Genetics, a biotechnology company developing a broad pipeline of protein-based
pharmaceutical and non-pharmaceutical products, announced receipt of the second
and final scheduled license payment from its royalty-bearing license and sales
agreement with Lonza Inc.
MDS Nordion of Kanata has entered into a research and development partnership
with Macrocyclics Inc. to develop innovative, bifunctional chelates for use
in molecular imaging and targeted therapeutic drugs.
Ablynx, a pioneer in the discovery and development of Nanobodies, a novel class
of therapeutic proteins derived from single-domain antibody fragments, announced
that it has signed a collaborative research, development and license agreement
with the Ottawa-based National Research Council of Canada (NRC) Institute for
Biological Sciences (IBS).
Australian-based biopharmaceutical company Apollo Life Sciences Ltd lodged its
prospectus with ASIC to raise $9.5 million in a June Initial Public Offer, underwritten
by Blackwood Capital.
Japan's Ono Pharmaceuticals said on Thursday it had decided to stop U.S. clinical
studies on its acute stroke drug Proglia, on which it had given overseas rights
to Merck & Co.
North China's Shanxi province
is taking urgent measures to crack down on fake and inferior traditional Chinese
medicines and materials, which are rampant on markets, according to the provincial
health administrative department.
Nigerian pharmaceutical companies concerned about growing calls to overturn
a ban on cheap imports have alleged that the previous trade regime allowed for
widespread "dumping" on the local market.
In the wake of recent stellar growth in Brazil's US$5bn retail drug market,
a local consumer group has criticised apparently "infralegal" practices
that have boosted profitability in the pharmacy sector.